A detailed history of Alpha Core Capital LLC transactions in Haleon PLC stock. As of the latest transaction made, Alpha Core Capital LLC holds 46,615 shares of HLN stock, worth $447,037. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,615
Previous 26,504 75.88%
Holding current value
$447,037
Previous $274,000 52.55%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$8.72 - $10.35 $175,367 - $208,148
20,111 Added 75.88%
46,615 $418,000
Q2 2025

Aug 12, 2025

BUY
$9.27 - $11.41 $58,623 - $72,156
6,324 Added 31.34%
26,504 $274,000
Q1 2025

May 09, 2025

SELL
$9.02 - $10.67 $4,843 - $5,729
-537 Reduced 2.59%
20,180 $207,000
Q2 2024

Aug 12, 2024

BUY
$8.01 - $8.64 $2,403 - $2,592
300 Added 1.47%
20,717 $171,000
Q2 2023

Aug 09, 2023

BUY
$8.04 - $9.0 $164,152 - $183,753
20,417 New
20,417 $171,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Alpha Core Capital LLC Portfolio

Follow Alpha Core Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Core Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Core Capital LLC with notifications on news.